ACRO BIOMEDICAL CO., LTD. (ACBM) Shareholders’ equity 2017–2025
ACRO BIOMEDICAL CO., LTD. (ACBM) shareholders’ equity at each fiscal year-end, per SEC filings.
-$386,964FY2025 · since FY2017: $511,331 → -$386,964
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$386,964 | -31.2% |
| FY2024 | -$294,972 | -14.8% |
| FY2023 | -$257,014 | -152.8% |
| FY2022 | $486,370 | -24.4% |
| FY2021 | $643,707 | -6.1% |
| FY2020 | $685,868 | -14.1% |
| FY2019 | $798,239 | -35.7% |
| FY2018 | $1.2M | +142.9% |
| FY2017 | $511,331 | — |
Source: SEC XBRL filings · For reference only · Not investment advice